Editorial November-2019 What do we have to learn

Rajiv Parikh

25 Jan 2020
Mylan – a global pharmaceutical company, is working with Drug Controller General of India (DCGI) to launch pretomanid, a medicine used to treat drug- resistant tuberculosis (TB), a top official of the US drug major has said. This drug is important for India because Prime Minister Narendra Modi said India would get rid of tuberculosis by 2025, he added. Also, Modi launched a campaign to eradicate TB from India by 2025, five years ahead of a globally-set deadline. TB Alliance was currently advancing the development of pretomanid in three ongoing late-stage clinical trials, Mylan had said in April. Mylan’s roots are in the U.S., and their products can likely be found in most American homes. In 2017 alone, Mylan’s generics saved the nation’s healthcare system approximately $20.4 billion.

For Indian pharma companies, supplying low-cost drugs globally, balancing the interests of shareholders with those of patients was not so difficult till the US FDA came down heavily on the manufacturing practices of some of the companies. Now, any lapse in ensuring patient safety is becoming a reason for erosion of shareholder wealth. Quality control, compliance with best manufacturing practices and drug safety have become very important to ensure that margins, returns and sales are stable. Drug major Sun Pharmaceutical Industries on Monday said it has launched ophthalmic solution Cequa, used for the treatment of dry eye disease in the US market. One of the company's wholly-owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said in a filing to BSE. Shares of Sun Pharmaceutical Industries (up 1.97 per cent) , Divi's Laboratories (up 1.42 per cent) and Piramal EnterprisesNSE 1.52% (up 0.90 per cent) were trading with gains.

In other news, a transporter and an employee of a pharmaceutical company have been booked for cheating, after unidentified suspects replaced four drums of rifampicin – a high grade antibiotic used to treat bacterial infections including tuberculosis, leprosy and others, while transporting it to Mumbai. The act of breaking the seal of the four drums has caused a loss of over Rs 10 lakh to the Chikalthana MIDC based pharmaceutical company. India has called for a "clear roadmap" from China to meet its long standing demand to open up Chinese pharmaceutical market for Indian exports as the drug regulators of both the nations held their first ever meeting on Friday in Shanghai, brain storming on removing the road blocks. June 27 is celebrated as international micro, small & medium-sized enterprises (MSMEs) day. It an also be termed as backbone of India's economy. In accordance to this, Google India has been providing online marketing solutions to empower small and medium business digitally since technology is the future and everyone is aiming towards expanding their business worldwide.

RedCarpet365 Ltd is organizing 5th Bangladesh Int’l Dyes, Pigments and Chemicals Expo 2019, from 07 to 10 November 2019 at International Convention City Bashundhara - ICCB, Dhaka – Bangladesh. Dyes, Dyestuffs, Pigments and all kind of Chemicals - Manufacturer, Suppliers & Exporters from Home & Abroad will participate at this mega exhibition. Targeting the entire Textile, Garment & Apparel industry of Bangladesh, we have 3 concurrent expos - 5th Bangladesh Int’l Garment & Textile Machinery Expo, 5th Bangladesh Int'l Printing, Packaging and Signage Expo and 5th Bangladesh Int’l Dyes, Pigments and Chemicals Expo. Chemical Market Magazine is a media partner with the exhibition and is looking forward to attending it this year.

Our LEADS platform chemicalmarket.net is achieving it’s target and is now open to all chemical industry. This platform helps the potential manufacturers, distributors and traders (in the chemical industry) to upload their product online and expand their business globally. Purchasers can also put on buy enquires online for free. You can also find our magazine available on the portal alongside events, conferences, latest news, interviews, reports and chemical prices subscription.


editorial More

Contact Now
Have a question or feedback, let us know!

Please enter the string as shown above: